StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Granted FDA Approval for SUTENT (sunitinib malate)
November 16, 2017 4:59 PM
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Hot FDA News
Management Comments
Next Articles
Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
November 16, 2017 4:58 PM
Maverick's 13F Shows New Stakes in Microsoft (MSFT), T-Mobile (TMUS), Increase in Envision (EVHC) (More)
November 14, 2017 11:31 AM